期刊文献+

特发性膜性肾病患者外周血单个核细胞中GRα和GRβ的表达与临床缓解的相关性 被引量:6

Idiopathic membranous nephropathy patients with peripheral blood mononuclear cells of GRα/β correlation to clinical remission
在线阅读 下载PDF
导出
摘要 目的:探讨特发性膜性肾病(IMN)患者外周血中单个核细胞(PBMC)中GRα和GRβ与临床缓解的相关性。方法:选取大连医科大学附属一院肾内科2013年10月至2015年3月经肾活检确诊为IMN的患者26例,所有IMN患者在糖皮质激素治疗8周后联合他克莫司;同时选取健康志愿者10例为对照组。分别留取患者在发病时(基线)、糖皮质激素治疗8周和达到缓解时清晨空腹血标本,提取外周血中单个核细胞,同时每月检测尿蛋白定量、血清白蛋白和肾功能。进行12个月的跟踪随访。采用Real Time PCR检测PBMC中GRα和GRβmRNA的差异,采用Western blot检测GRα和GRβ的蛋白表达差异,COX回归分析IMN患者PBMC中GRα/β与临床缓解的相关性。结果:26例IMN完全缓解(CR) 9例,部分缓解(PR) 6例,未缓解(NR) 11例。RT-PCR结果显示:与对照组相比,IMN组PBMC中GRα的表达降低(P<0. 05),而GRβ的表达明显升高(P<0. 05);GRα/GRβ明显降低(P<0. 05)。Western blot检测结果显示:与对照组相比,IMN组GRα的蛋白表达无变化(P>0. 05),而GRβ的蛋白表达明显增高(P<0. 05)。COX回归分析结果显示:年龄、病程、血压、24 h尿蛋白定量、白蛋白、肌酐、胆固醇、三酰甘油、纤维蛋白原与临床缓解无明显相关性(P>0. 05),基线时GRα/β基因表达与临床缓解有关(P<0. 05)。结论:IMN患者PBMC中基线GRαmRNA与GRα/βmRNA与临床缓解呈正相关。 Objective:To explore the relationship between expression of GRα/βin peripheral blood mononuclear cells of patients with idiopathic membranous nephropathy(IMN)and clinical.Methods:Choose 26 patients with IMN by renal biopsy diagnosis as IMN group between October 2013 and March 2015 in the First Hospital of Dalian Medical University,10 cases of health blood donors as control group.In the law of sufficient glucocorticoid treatment after 8 weeks,combined with the using of tacrolimus.Record IMN patients baseline,glucocorticoid treatment for 8 weeks and to achieve complete remission or partial remission within a weekend,the 24 h urine protein,albumin,cholesterol,creatinine.IMN patients were followed up at 12 months.By Real Time PCR method to detect PBMC of GRαmRNA and GRβmRNA gene expression differences,and using Western blot method to detect PBMC of GRαand GRβprotein expression differences.COX regression analysis the relevance in patients with IMN in PBMC GRα/βcorrelation to clinical remission.Results:The follow-up study of 26 IMN patients,9 patients with CR,PR in 6 patients,11 patients with NR.RT-PCR results showed that there were lower expressions of GRαmRNA and higher expressions of GRβmRNA in PBMC from IMN group than those in control group(P<0.05).Western blot results showed that there were no significant change of GRαprotein between IMN group and control group.But,the higher expressions of GRβprotein in PBMC from IMN group than those in control group(P<0.05).COX regression analyses showed that clinical remission was negatively correlated with age,course of disease,hypertension,24 h urine protein,albumin,creatinine,cholesterol,triglyceride and fibrinogen.But positively correlated with the gene expression of GRα/βat baseline.Conclusion:Baseline IMN patients with GRαand GRα/βin PBMC gene expression have correlation with clinical remission.
作者 孙艳玲 谢华 林洪丽 刘颖 张圣坤 SUN Yan-Ling;XIE Hua;LIN Hong-Li;LIU Ying;ZHANG Sheng-Kun(The First Hospital of Dalian Medical University,Dalian 116011,China)
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2019年第12期1500-1504,共5页 Chinese Journal of Immunology
基金 中华医学会临床医学科研专项资金项目资助(No.15020100598)
关键词 特发性膜性肾病 糖皮质激素 糖皮质激素受体 外周血单个核细胞 Idiopathic membranous nephropathy Glucocorticoid Glucocorticoid receptors Peripheral blood mononuclear cell
作者简介 孙艳玲,女,硕士,副主任医师,主要从事肾小球疾病方面的研究,E-mail:yanlingsun916@sina.com;通讯作者:谢华,女,博士,主任医师,主要从事肾小球疾病方面的研究,E-mail:wlciq007@163.com。
  • 相关文献

参考文献1

二级参考文献181

  • 1Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JR, Aun- ins J. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 1992; 356: 768-774.
  • 2Jin Y, Birlea SA, Fain PR, Spritz RA. Genetic variations in NALP1 are associated with generalized vitiligo in a Romanian population. J Invest Dermatol 2007; 127:2558-2562.
  • 3Jin Y, Mailloux CM, Gowan K, Riccardi SL, LaBerge G, Bennett DC, Fain PR, Spritz RA. NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med 2007; 356:1216-1225.
  • 4Magitta NF, Boe Wolff AS, Johansson S, Skinningsrud B, Lie BA, Myhr KM, Undlien DE, Joner G, Njolstad PR, Kvien TK, Forre O, Knappskog PM, Husebye ES. A coding polymor- phism in NALP1 confers risk for autoimmune Addison's dis- ease and type I diabetes. Genes Immun 2009; 10:120-124.
  • 5Tracey KJ,-Cerami A. Tumor necrosis factor: a pleiotropic cy- tokine and therapeutic target. Annu Rev Med 1994; 45:491-503.
  • 6Carroll MC, Katzman P, Alicot EM, KoUer BH, Geraghty DE, Orr HT, Strominger JL, Spies T. Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes. Proc Natl Acad Sci USA 1987; 84:8535-8539.
  • 7Harney SM, Newton JL, Wordsworth BP. Molecular genetics of rheumatoid arthritis. Curr Opin Pharmacol 2003; 3:280-285.
  • 8Elahi MM, Asotra K, Matata BM, Mastana SS. Tumor necro- sis factor alpha -308 gene locus promoter polymorphism: an analysis of association with health and disease. Biochim Biophys Acta 2009; 1792:163-172.
  • 9Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LB, Duff GW. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associ- ated with HLA A1, B8, and DR3 alleles. J Exp Med 1993; 177: 557-560.
  • 10McManus R, Wilson AG, Mansfield J, Weir DG, Duff GW, Kelleher D. TNF2, a polymorphism of the tumour necrosis-al- pha gene promoter, is a component of the celiac disease major histocompatibility complex haplotype. Eur J Immunol 1996; 26: 2113-2118.

共引文献13

同被引文献59

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部